Resona Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.2M | Buy |
43,700
+4,780
| +12% | +$1.56M | 0.07% | 267 |
|
|
2025
Q1 | $10.5M | Buy |
38,920
+2,264
| +6% | +$611K | 0.06% | 286 |
|
|
2024
Q4 | $8.64M | Sell |
36,656
-921
| -2% | -$217K | 0.05% | 327 |
|
|
2024
Q3 | $10.3M | Sell |
37,577
-5,890
| -14% | -$1.62M | 0.06% | 296 |
|
|
2024
Q2 | $10.6M | Sell |
43,467
-3,474
| -7% | -$846K | 0.06% | 281 |
|
|
2024
Q1 | $7.02M | Buy |
+46,941
| New | +$7.02M | 0.04% | 378 |
|